Claussen D W
Gastroenterol Nurs. 1993 Dec;16(3):136-7. doi: 10.1097/00001610-199312000-00010.
Pentasa (mesalamine) is a newly released oral 5-aminosalicylic acid capsule marketed by Marion Merrel Dow Inc., for the induction of remission and for the treatment of mildly to moderately active ulcerative colitis. Ulcerative colitis is a chronic inflammatory disease and the most common form of inflammatory bowel disease, which is a debilitating and unpredictable group of illnesses affecting the gastrointestinal tracts of over 2 million Americans. Pentasa causes few side effects and is generally well tolerated.
颇得斯安(美沙拉嗪)是由美国家庭用品公司新推出的口服5-氨基水杨酸胶囊,用于诱导缓解及治疗轻至中度活动性溃疡性结肠炎。溃疡性结肠炎是一种慢性炎症性疾病,也是炎症性肠病最常见的形式,是一组影响超过200万美国人胃肠道的使人衰弱且不可预测的疾病。颇得斯安副作用少,一般耐受性良好。